BPP, a dual functional inhibitor, targets MLL-rearranged acute myeloid leukemia: Unraveling mechanisms and expanding therapeutic horizons

被引：0
|
作者：
Chen, Tai-Lin
Su, Tsann-Long
Lee, Te-Chang
机构：
来源：
CANCER RESEARCH | 2024年 / 84卷 / 06期
关键词：
D O I：
10.1158/1538-7445.AM2024-3330
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3330
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Co-inhibition of HDAC and MLL-menin interaction targets MLL-rearranged acute myeloid leukemia cells via disruption of DNA damage checkpoint and DNA repair
    Ye, Jing
    Zha, Jie
    Shi, Yuanfei
    Li, Yin
    Yuan, Delin
    Chen, Qinwei
    Lin, Fusheng
    Fang, Zhihong
    Yu, Yong
    Dai, Yun
    Xu, Bing
    CLINICAL EPIGENETICS, 2019, 11 (01)
  • [42] Gene expression profiling of pediatric MLL-rearranged leukemia:: Relation between acute lymphoblastic leukemia, acute myeloid leukemia, and leukemic cell lines.
    Ishii, Masami
    Tsutsumi, Shuichi
    Taki, Tomohiko
    Nishimura, Kunihiro
    Ge, Xijin
    Tsuchida, Masahiro
    Ohki, Misao
    Bessho, Fumio
    Sugita, Kanji
    Ishii, Eiichi
    Ichikawa, Hitoshi
    Aburatani, Hiroyuki
    Hayashi, Yasuhide
    BLOOD, 2006, 108 (11) : 192B - 192B
  • [43] NG2 antigen is a therapeutic target for MLL-rearranged B-cell acute lymphoblastic leukemia
    Belen Lopez-Millan
    Diego Sanchéz-Martínez
    Heleia Roca-Ho
    Francisco Gutiérrez-Agüera
    Oscar Molina
    Rafael Diaz de la Guardia
    Raúl Torres-Ruiz
    Jose Luís Fuster
    Paola Ballerini
    Ute Suessbier
    Cesar Nombela-Arrieta
    Clara Bueno
    Pablo Menéndez
    Leukemia, 2019, 33 : 1557 - 1569
  • [44] NG2 antigen is a therapeutic target for MLL-rearranged B-cell acute lymphoblastic leukemia
    Lopez-Millan, Belen
    Sanchez-Martinez, Diego
    Roca-Ho, Heleia
    Gutierrez-Aguera, Francisco
    Molina, Oscar
    Diaz de la Guardia, Rafael
    Torres-Ruiz, Raul
    Luis Fuster, Jose
    Ballerini, Paola
    Suessbier, Ute
    Nombela-Arrieta, Cesar
    Bueno, Clara
    Menendez, Pablo
    LEUKEMIA, 2019, 33 (07) : 1557 - 1569
  • [45] Co-inhibition of HDAC and MLL-menin interaction targets MLL-rearranged acute myeloid leukemia cells via disruption of DNA damage checkpoint and DNA repair
    Jing Ye
    Jie Zha
    Yuanfei Shi
    Yin Li
    Delin Yuan
    Qinwei Chen
    Fusheng Lin
    Zhihong Fang
    Yong Yu
    Yun Dai
    Bing Xu
    Clinical Epigenetics, 2019, 11
  • [46] Bruton’s tyrosine kinase and RAC1 promote cell survival in MLL-rearranged acute myeloid leukemia
    S C Nimmagadda
    S Frey
    B Edelmann
    C Hellmich
    L Zaitseva
    G M König
    E Kostenis
    K M Bowles
    T Fischer
    Leukemia, 2018, 32 : 846 - 849
  • [47] Bruton's tyrosine kinase and RAC1 promote cell survival in MLL-rearranged acute myeloid leukemia
    Nimmagadda, S. C.
    Frey, S.
    Edelmann, B.
    Hellmich, C.
    Zaitseva, L.
    Koenig, G. M.
    Kostenis, E.
    Bowles, K. M.
    Fischer, T.
    LEUKEMIA, 2018, 32 (03) : 846 - 849
  • [48] KRAS mutations Frequently Coexist with High-Risk MLL Fusions and Are Independent Adverse Prognostic Factors in MLL-Rearranged Acute Myeloid Leukemia
    Matsuo, Hidemasa
    Yoshida, Kenichi
    Nakatani, Kana
    Harata, Yutarou
    Higashitani, Moe
    Ito, Yuri
    Kamikubo, Yasuhiko
    Shiozawa, Yusuke
    Shiraishi, Yuichi
    Chiba, Kenichi
    Tanaka, Hiroko
    Okada, Ai
    Nannya, Yasuhito
    Takeda, June
    Ueno, Hiroo
    Kiyokawa, Nobutaka
    Tomizawa, Daisuke
    Taga, Takashi
    Tawa, Akio
    Miyano, Satoru
    Meggendorfer, Manja
    Haferlach, Claudia
    Ogawa, Seishi
    Adachi, Souichi
    BLOOD, 2020, 136
  • [49] COOPERATIVE MUTATION STUDY IN KOREAN PATIENTS WITH MLL-REARRANGED ACUTE MYELOID LEUKEMIA USING TARGETED NEXT GENERATION SEQUENCING
    Kim, S. Y.
    Yang, J. J.
    Park, T. S.
    Lee, W. I.
    Cho, E. H.
    Meyer, C.
    Marschalek, R.
    Lee, S. T.
    Kim, H. J.
    Kim, S. H.
    Cho, Y. U.
    Jang, S.
    Park, C. J.
    HAEMATOLOGICA, 2015, 100 : 360 - 361
  • [50] MEK inhibition is a promising therapeutic strategy for MLL-rearranged infant acute lymphoblastic leukemia patients carrying RAS mutations
    Kerstjens, Mark
    Driessen, Emma M. C.
    Willekes, Merel
    Pinhancos, Sandra S.
    Schneider, Pauline
    Pieters, Rob
    Stam, Ronald W.
    ONCOTARGET, 2017, 8 (09) : 14835 - 14846
12345